COR

SELL

Cencora, Inc.

Healthcare · Rank #285 · Analyzed Jul 13, 2026

$303.44

Current Price

$219.72

Intrinsic Value

low confidence

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueLow confidence — see rating

Fair Value Range

Low$104.70

Base (IV)$219.72

High$640.18

Entry Points

Conservative$73.29

Moderate$104.70

Aggressive$153.81

⚠️ Warnings

DCF/EPV diverge 4.3x — earnings power and cash flow disagree; fair value is low-confidence (blended conservatively)

Quality & Moat Breakdown

Return on Equity107.1% → 1.0/1.0

Debt LevelD/E 421 → 0/1.0

Revenue QualityGrowth 9.1%, margin Δ+0.2% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins0.8% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.